vs
Side-by-side financial comparison of ACHIEVE LIFE SCIENCES, INC. (ACHV) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $699.9M | ||
| Q2 25 | — | $613.9M | ||
| Q1 25 | — | $692.8M | ||
| Q4 24 | — | $707.8M | ||
| Q3 24 | — | $727.1M | ||
| Q2 24 | — | $637.0M | ||
| Q1 24 | — | $711.0M | ||
| Q4 23 | — | $742.6M |
| Q3 25 | — | $-733.0M | ||
| Q2 25 | — | $-255.4M | ||
| Q1 25 | — | $-12.7M | ||
| Q4 24 | — | $-178.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-147.7M | ||
| Q1 24 | — | $-1.7B | ||
| Q4 23 | — | $7.0M |
| Q3 25 | — | -100.7% | ||
| Q2 25 | — | -29.4% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | -18.4% | ||
| Q1 24 | — | -247.3% | ||
| Q4 23 | — | 5.4% |
| Q3 25 | — | -104.7% | ||
| Q2 25 | — | -41.6% | ||
| Q1 25 | — | -1.8% | ||
| Q4 24 | — | -25.2% | ||
| Q3 24 | — | -2.7% | ||
| Q2 24 | — | -23.2% | ||
| Q1 24 | — | -239.9% | ||
| Q4 23 | — | 0.9% |
| Q3 25 | — | $-10.78 | ||
| Q2 25 | — | $-3.77 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-2.54 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $-2.20 | ||
| Q1 24 | — | $-25.50 | ||
| Q4 23 | — | $0.11 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
